These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 16214782)

  • 1. Dissolution stability studies of suspensions of prolonged-release diclofenac microcapsules prepared by the Wurster process: I. Eudragit-based formulation and possible drug-excipient interaction.
    Adeyeye MC; Mwangi E; Katondo B; Jain A; Ichikawa H; Fukumori Y
    J Microencapsul; 2005 Jun; 22(4):333-42. PubMed ID: 16214782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suspensions of prolonged-release diclofenac-Eudragit and ion-exchange resin microcapsules: II. Improved dissolution stability.
    Adeyeye MC; Mwangi E; Katpally S; Fujioka K; Ichikawa H; Fukumori Y
    J Microencapsul; 2005 Jun; 22(4):353-62. PubMed ID: 16214784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of plasticizer on release kinetics of diclofenac sodium pellets coated with Eudragit RS 30 D.
    Kibria G; Roni MA; Absar MS; Jalil RU
    AAPS PharmSciTech; 2008; 9(4):1240-6. PubMed ID: 19101805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal growth formation in melt extrudates.
    Bruce C; Fegely KA; Rajabi-Siahboomi AR; McGinity JW
    Int J Pharm; 2007 Aug; 341(1-2):162-72. PubMed ID: 17524578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged release from orodispersible films by incorporation of diclofenac-loaded micropellets.
    Speer I; Lenhart V; Preis M; Breitkreutz J
    Int J Pharm; 2019 Jan; 554():149-160. PubMed ID: 30414477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel controlled release solid dispersion for the delivery of diclofenac sodium.
    Giri TK; Kumar K; Alexander A; Ajazuddin ; Badwaik H; Tripathy M; Tripathi DK
    Curr Drug Deliv; 2013 Aug; 10(4):435-43. PubMed ID: 23517623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of ion-exchange resins to prepare 100 microm-sized microcapsules with prolonged drug-release by the Wurster process.
    Ichikawa H; Fujioka K; Adeyeye MC; Fukumori Y
    Int J Pharm; 2001 Mar; 216(1-2):67-76. PubMed ID: 11274808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro dissolution studies of sodium diclofenac granules coated with Eudragit L-30D-55 by fluidized-bed system.
    Silva OS; Souza CR; Oliveira WP; Rocha SC
    Drug Dev Ind Pharm; 2006 Jul; 32(6):661-7. PubMed ID: 16885121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative evaluation of interpolyelectrolyte complexes of chitosan with Eudragit L100 and Eudragit L100-55 as potential carriers for oral controlled drug delivery.
    Moustafine RI; Margulis EB; Sibgatullina LF; Kemenova VA; Van den Mooter G
    Eur J Pharm Biopharm; 2008 Sep; 70(1):215-25. PubMed ID: 18691856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of reconstitutable suspensions containing diclofenac sodium-loaded microspheres for pediatric delivery.
    Oz UC; Devrim B; Bozkır A; Canefe K
    J Microencapsul; 2015; 32(4):317-28. PubMed ID: 26154114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of an enteric polymer on drug release rates of theophylline from pellets coated with Eudragit RS 30D.
    Wu C; McGinity JW
    Pharm Dev Technol; 2003; 8(1):103-10. PubMed ID: 12665203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hot melt extrusion (HME) for amorphous solid dispersions: predictive tools for processing and impact of drug-polymer interactions on supersaturation.
    Sarode AL; Sandhu H; Shah N; Malick W; Zia H
    Eur J Pharm Sci; 2013 Feb; 48(3):371-84. PubMed ID: 23267847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controlled release of a poorly water-soluble drug from hot-melt extrudates containing acrylic polymers.
    Zhu Y; Shah NH; Malick AW; Infeld MH; McGinity JW
    Drug Dev Ind Pharm; 2006 Jun; 32(5):569-83. PubMed ID: 16720412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Technological and pharmacotherapeutic properties of selected drugs with modified release of diclofenac sodium].
    Kołodziejczyk MK; Kołodziejska J; Zgoda MM
    Polim Med; 2012; 42(2):121-32. PubMed ID: 23016443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accelerated stability of sulphamethoxazole microcapsules coated with Eudragit RS 100 and Eudragit RL 100.
    Basnet S; Ganesan M; Pal TK
    Boll Chim Farm; 2002; 141(3):202-9. PubMed ID: 12197419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the sustained release properties of Eudragit RS, RL and S (acrylic resins) microcapsules containing ketoprofen in beagle dogs.
    Goto S; Kawata M; Nakamura M; Nagatsuma Y; Fujinaga K; Aoyama T
    J Microencapsul; 1988; 5(4):343-60. PubMed ID: 3236155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Preparation of tablets containing enteric-coated diclofenac sodium pellets].
    Qi XL; Zhu JB; Chen SJ
    Yao Xue Xue Bao; 2008 Jan; 43(1):97-101. PubMed ID: 18357741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Eudragit RS-PO and Ethocel 100 matrices for the controlled release of lobenzarit disodium.
    Boza A; Caraballo I; Alvarez-Fuentes J; Rabasco AM
    Drug Dev Ind Pharm; 1999 Feb; 25(2):229-33. PubMed ID: 10065357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physical characterization and dissolution properties of ibuprofen: Eudragit coprecipitates.
    Kislalioglu MS; Khan MA; Blount C; Goettsch RW; Bolton S
    J Pharm Sci; 1991 Aug; 80(8):799-804. PubMed ID: 1791544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eudragit RS and RL (acrylic resins) microcapsules as pH insensitive and sustained release preparations of ketoprofen.
    Goto S; Kawata M; Nakamura M; Maekawa K; Aoyama T
    J Microencapsul; 1986; 3(4):293-304. PubMed ID: 3508190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.